Cargando…
The therapy of idiopathic pulmonary fibrosis: what is next?
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease, characterised by progressive scarring of the lung and associated with a high burden of disease and early death. The pathophysiological understanding, clinical diagnostics and therapy of IPF have signi...
Autores principales: | Somogyi, Vivien, Chaudhuri, Nazia, Torrisi, Sebastiano Emanuele, Kahn, Nicolas, Müller, Veronika, Kreuter, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488691/ https://www.ncbi.nlm.nih.gov/pubmed/31484664 http://dx.doi.org/10.1183/16000617.0021-2019 |
Ejemplares similares
-
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme
por: Valenzuela, Claudia, et al.
Publicado: (2020) -
Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018) -
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2019) -
Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review
por: Hayton, Conal, et al.
Publicado: (2019) -
Transbronchial Lung Cryobiopsy in Idiopathic Pulmonary Fibrosis: A State of the Art Review
por: Lodhi, Taha, et al.
Publicado: (2019)